Haploinsufficiency of the E3 ubiquitin ligase C-Terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  McLaughlin, BethAnn ^a,b   Buendia, Matthew A ^a   Saborido, Tommy P ^a   Palubinsky, Amy M ^a,b   Stankowski, Jeannette N ^a   Stanwood, Gregg D ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C TERMINUS OF HEAT SHOCK COGNATE 70 INTERACTING PROTEIN; HEAT SHOCK COGNATE PROTEIN 70; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CHIP PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY TEMPERATURE; BRAIN FUNCTION; BRAIN WEIGHT; BREATHING PATTERN; CELL FATE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL STRESS; HAPLOINSUFFICIENCY; HEART FUNCTION; HEART RATE; HETEROZYGOTE; KNOCKOUT MOUSE; MODULATION; MOTOR DYSFUNCTION; MOUSE; MOUSE MUTANT; MUSCLE TONE; NONHUMAN; PROTEIN EXPRESSION; SENSORIMOTOR FUNCTION; TASK PERFORMANCE; ANIMAL; ANXIETY; EMOTION; GENETICS; MALE; MAZE TEST; MOTIVATION; MOTOR ACTIVITY; MOTOR PERFORMANCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; EMOTIONS; HAPLOINSUFFICIENCY; MALE; MAZE LEARNING; MICE; MICE, MUTANT STRAINS; MOTIVATION; MOTOR ACTIVITY; MOTOR SKILLS; UBIQUITIN-PROTEIN LIGASES;

EID: 84860999545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036340     Document Type: Article

References (52)

1. Kiang JG, Tsokos GC, (1998) Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 80: 183-201.
2. Dirnagl U, Becker K, Meisel A, (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8: 398-412.
3. O'Duffy AE, Bordelon YM, McLaughlin B, (2007) Killer proteases and little strokes-how the things that do not kill you make you stronger. J Cereb Blood Flow Metab 27: 655-668.
4. Lipton P, (1999) Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568.
5. Arndt V, Rogon C, Höhfeld J, (2007) To be, or not to be - molecular chaperones in protein degradation. Cellular and Molecular Life Sciences 64: 2525-2541.
6. Hohfeld J, Cyr DM, Patterson C, (2001) From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep 2: 885-890.
7. Qian SB, McDonough H, Boellmann F, Cyr DM, Patterson C, (2006) CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature 440: 551-555.
8. Kundrat L, Regan L, (2010) Identification of residues on Hsp70 and Hsp90 ubiquitinated by the cochaperone CHIP. Journal of Molecular Biology 395: 587-594.
9. McDonough H, Charles PC, Hilliard EG, Qian S-B, Min J-n, et al. (2009) Stress-dependent CHIP/DAXX interaction suppresses the p53 apoptotic program. Journal of Biological Chemistry pp. 20649-20659.
10. Shimura H, Schwartz D, Gygi SP, Kosik KS, (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. Journal of Biological Chemistry 279: 4869-4876.
11. Sahara N, Murayama M, Mizoroki T, Urushitani M, Imai Y, et al. (2005) In vivo evidence of CHIP up-regulation attenuating tau aggregation. Journal of Neurochemistry 94: 1254-1263.
12. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, et al. (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Human Molecular Genetics 13: 703-714.
13. Zhang Q-g, Han D, Wang R-m, Dong Y, Yang F, et al. (2011) C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-α and the critical period hypothesis of estrogen neuroprotection. Proceedings of the National Academy of Sciences.
14. Fan M, Park A, Nephew KP, (2005) CHIP (Carboxyl Terminus of Hsc70-Interacting Protein) promotes basal and geldanamycin-induced degradation of estrogen receptor- alpha. Molecular Endocrinology (Baltimore, Md) 19: 2901.
15. Dickey CA, Patterson C, Dickson D, Petrucelli L, (2007) Brain CHIP: removing the culprits in neurodegenerative disease. Trends in Molecular Medicine 13: 32.
16. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, et al. (2002) CHIP Is Associated with Parkin, a gene responsible for familial Parkinson's Disease, and enhances its ubiquitin ligase activity. Molecular Cell 10: 55-67.
17. Stankowski JN, Zeiger SL, Cohen EL, DeFranco DB, Cai J, et al. (2011) C-terminus of heat shock cognate 70 interacting protein increases following stroke and impairs survival against acute oxidative stress. Antioxid Redox Signal 14: 1787-1801.
18. Dai Q, Zhang C, Wu Y, McDonough H, Whaley RA, et al. (2003) CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J 22: 5446-5458.
19. Min J-N, Whaley RA, Sharpless NE, Lockyer P, Portbury AL, et al. (2008) CHIP Deficiency Decreases Longevity, with Accelerated Aging Phenotypes Accompanied by Altered Protein Quality Control. Mol Cell Biol 28: 4018-4025.
20. Zeiger SLH, Musiek ES, Zanoni G, Vidari G, Morrow JD, et al. (2009) Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury. Free Radical Biology and Medicine 47: 1422-1431.
21. McLaughlin B, Levitt P, (2000) Molecular basis of neurological disease.; In: Wong-Reiley MTT, editors. Philadelphia Hanley and Belfus Inc.
22. Lin MT, Beal MF, (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787.
23. Ng F, Berk M, Dean O, Bush AI, (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11: 851-876.
24. Hovatta I, Juhila J, Donner J, (2010) Oxidative stress in anxiety and comorbid disorders. Neurosci Res 68: 261-275.
25. Qiu S, Korwek KM, Pratt-Davis AR, Peters M, Bergman MY, et al. (2006) Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol Learn Mem 85: 228-242.
26. Laviola G, Ognibene E, Romano E, Adriani W, Keller F, (2009) Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes. Neurosci Biobehav Rev 33: 560-572.
27. Yao I, Takao K, Miyakawa T, Ito S, Setou M, (2011) Synaptic E3 ligase SCRAPPER in contextual fear conditioning: extensive behavioral phenotyping of Scrapper heterozygote and overexpressing mutant mice. PLoS One 6: e17317.
28. Kalueff AV, Ren-Patterson RF, Murphy DL, (2007) The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends Pharmacol Sci 28: 122-127.
29. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, et al. (2010) Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 39: 169-180.
30. Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, et al. (2007) Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav 6: 411-424.
31. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, et al. (2003) Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 23: 622-631.
32. Gustin RM, Shonesy BC, Robinson SL, Rentz TJ, Baucum AJ 2nd, et al. (2011) Loss of Thr286 phosphorylation disrupts synaptic CaMKIIalpha targeting, NMDAR activity and behavior in pre-adolescent mice. Mol Cell Neurosci 47: 286-292.
33. Thompson BL, Levitt P, Stanwood GD, (2005) Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behav Brain Res 164: 107-116.
34. Stanwood GD, Levitt P, (2007) Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine. Synapse 61: 259-262.
35. Irwin S, (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13: 222-257.
36. Olsen CM, Childs DS, Stanwood GD, Winder DG, (2010) Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5). PLoS One 5: e15085.
37. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, et al. (1999) Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19: 4535-4545.
38. McDonough H, Patterson C, (2003) CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 8: 303-308.
39. Murata S, Minami Y, Minami M, Chiba T, Tanaka K, (2001) CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep 2: 1133-1138.
40. Belzung C, Griebel G, (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125: 141-149.
41. Whitney G, (1970) Timidity and fearfulness of laboratory mice: An illustration of problems in animal temperament. Behavior Genetics 1: 77-85.
42. Hughes RN, (2004) The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev 28: 497-505.
43. Lalonde R, (2002) The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 26: 91-104.
44. Couppis MH, Kennedy CH, Stanwood GD, (2008) Differences in aggressive behavior and in the mesocorticolimbic DA system between A/J and BALB/cJ mice. Synapse 62: 715-724.
45. Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, et al. (2011) Absence of preference for social novelty and increased grooming in integrin beta3 knockout mice: initial studies and future directions. Autism Res 4: 57-67.
46. Moy SS, Nadler JJ, Young NB, Nonneman RJ, Segall SK, et al. (2008) Social approach and repetitive behavior in eleven inbred mouse strains. Behav Brain Res 191: 118-129.
47. Friguet B, (2006) Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett 580: 2910-2916.
48. von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, et al. (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proceedings of the National Academy of Sciences of the United States of America 101: 10744-10749.
49. Perez FA, Palmiter RD, (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proceedings of the National Academy of Sciences 102: 2174-2179.
50. Abbas N, Lucking CB, Ricard S, Durr A, Bonifati V, et al. (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Human Molecular Genetics 8: 567-574.
51. Tsvetkov P, Adamovich Y, Elliott E, Shaul Y, (2011) E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem 286: 8839-8845.
52. Zhang GR, Cheng XR, Zhou WX, Zhang YX, (2008) Age-related expression of STUB1 in senescence-accelerated mice and its response to anti-Alzheimer's disease traditional Chinese medicine. Neurosci Lett 438: 371-375.